Prof. dr. G. (Gerrit) Storm

Hans Freudenthalgebouw
Budapestlaan 6
3584 CD Utrecht

Prof. dr. G. (Gerrit) Storm

Emeritus Professor
Pharmaceutics
g.storm@uu.nl

Publications

2023

Scholarly publications

Rousou, C., van Kronenburg, N., Sonnen, A. F. P., van Dijk, M., Moonen, C., Storm, G., Mastrobattista, E., & Deckers, R. (2023). Microbubble-Assisted Ultrasound for Drug Delivery to the Retina in an Ex Vivo Eye Model. Pharmaceutics, 15(4). https://doi.org/10.3390/pharmaceutics15041220

2022

Scholarly publications

Wong, C. W., Wong, E., Metselaar, J. M., Storm, G., & Wong, T. T. (2022). Liposomal drug delivery system for anti-inflammatory treatment after cataract surgery: a phase I/II clinical trial. Drug Delivery and Translational Research, 12(1), 7-14. https://doi.org/10.1007/s13346-021-00912-x
Szebeni, J., Storm, G., Ljubimova, J. Y., Castells, M., Phillips, E. J., Turjeman, K., Barenholz, Y., Crommelin, D. J. A., & Dobrovolskaia, M. A. (2022). Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines. Nature Nanotechnology, 17(4), 337-346. https://doi.org/10.1038/s41565-022-01071-x
Roemhild, K., Besse, H. C., Wang, B., Peña, Q., Sun, Q., Omata, D., Ozbakir, B., Bos, C., Scheeren, H. W., Storm, G., Metselaar, J. M., Yu, H., Knüchel-Clarke, R., Kiessling, F., Moonen, C. T. W., Deckers, R., Shi, Y., & Lammers, T. (2022). Ultrasound-directed enzyme-prodrug therapy (UDEPT) using self-immolative doxorubicin derivatives. Theranostics, 12(10), 4791-4801. https://doi.org/10.7150/THNO.69168
Kuninty, P. R., Binnemars-Postma, K., Jarray, A., Pednekar, K. P., Heinrich, M. A., Pijffers, H. J., ten Hoopen, H., Storm, G., van Hoogevest, P., den Otter, W. K., & Prakash, J. (2022). Cancer immune therapy using engineered ‛tail-flipping’ nanoliposomes targeting alternatively activated macrophages. Nature Communications, 13(1), 1-17. [4548]. https://doi.org/10.1038/s41467-022-32091-9
Estapé Senti, M., de Jongh, C. A., Dijkxhoorn, K., Verhoef, J. J. F., Szebeni, J., Storm, G., Hack, C. E., Schiffelers, R. M., Fens, M. H., & Boross, P. (2022). Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement. Journal of Controlled Release, 341, 475-486. https://doi.org/10.1016/j.jconrel.2021.11.042
Bagheri, M., van Nostrum, C. F., Kok, R. J., Storm, G., Hennink, W. E., & Heger, M. (2022). Utility of Intravenous Curcumin Nanodelivery Systems for Improving In Vivo Pharmacokinetics and Anticancer Pharmacodynamics. Molecular Pharmaceutics, 19(9), 3057–3074. https://doi.org/10.1021/acs.molpharmaceut.2c00455
Rousou, C., De Maar, J., Qiu, B., Van Der Wurff-Jacobs, K., Ruponen, M., Urtti, A., Oliveira, S., Moonen, C., Storm, G., Mastrobattista, E., & Deckers, R. (2022). The Effect of Microbubble-Assisted Ultrasound on Molecular Permeability across Cell Barriers. Pharmaceutics, 14(3), [494]. https://doi.org/10.3390/pharmaceutics14030494
Nijen Twilhaar, M. K., Czentner, L., Bouma, R. G., Olesek, K., Grabowska, J., Wang, A. Z., Affandi, A. J., Belt, S. C., Kalay, H., van Nostrum, C. F., van Kooyk, Y., Storm, G., & den Haan, J. M. M. (2022). Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses. Frontiers in Immunology, 13, 1-17. [842241]. https://doi.org/10.3389/fimmu.2022.842241

2021

Scholarly publications

Wei, Y., Sun, Y., Wei, J., Qiu, X., Meng, F., Storm, G., & Zhong, Z. (2021). Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo. Journal of controlled release : official journal of the Controlled Release Society, 337, 521-529. https://doi.org/10.1016/j.jconrel.2021.07.048
Sofias, A. M., De Lorenzi, F., Peña, Q., Azadkhah Shalmani, A., Vucur, M., Wang, J-W., Kiessling, F., Shi, Y., Consolino, L., Storm, G., & Lammers, T. (2021). Therapeutic and diagnostic targeting of fibrosis in metabolic, proliferative and viral disorders. Advanced Drug Delivery Reviews, 175, 1-36. [113831]. https://doi.org/10.1016/j.addr.2021.113831
Sofias, A. M., Combes, F., Koschmieder, S., Storm, G., & Lammers, T. (2021). A paradigm shift in cancer nanomedicine: from traditional tumor targeting to leveraging the immune system. Drug Discovery Today, 26(6), 1482-1489. https://doi.org/10.1016/j.drudis.2021.02.017
Rousou, C., Schuurmans, C. C. L., Urtti, A., Mastrobattista, E., Storm, G., Moonen, C., Kaarniranta, K., & Deckers, R. (2021). Ultrasound and Microbubbles for the Treatment of Ocular Diseases: From Preclinical Research towards Clinical Application. Pharmaceutics, 13(11), 1-35. [1782]. https://doi.org/10.3390/pharmaceutics13111782
Neupane, Y. R., Huang, C., Wang, X., Chng, W. H., Venkatesan, G., Zharkova, O., Wacker, M. G., Czarny, B., Storm, G., Wang, J-W., & Pastorin, G. (2021). Lyophilization Preserves the Intrinsic Cardioprotective Activity of Bioinspired Cell-Derived Nanovesicles. Pharmaceutics, 13(7), 1-19. [1052]. https://doi.org/10.3390/pharmaceutics13071052